194 related articles for article (PubMed ID: 6433044)
1. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study.
Freedman A; Ehrlich RM; Ljung BM
J Urol; 1984 Sep; 132(3):580-2. PubMed ID: 6433044
[TBL] [Abstract][Full Text] [Related]
2. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.
Ehrlich RM; Freedman A; Goldsobel AB; Stiehm ER
J Urol; 1984 May; 131(5):960-2. PubMed ID: 6423841
[TBL] [Abstract][Full Text] [Related]
3. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
Habs MR; Schmähl D
Cancer; 1983 Feb; 51(4):606-9. PubMed ID: 6401591
[TBL] [Abstract][Full Text] [Related]
4. Effect of the uroprotector sodium 2-mercaptoethane sulfonate (Mesna) on the proliferation of the bladder urothelium in the rat after administration of cyclophosphamide.
Kunze E; Köhnecke B; Engelhardt W; Steinröder H; Brock N; Pohl J
Urol Int; 1984; 39(2):61-7. PubMed ID: 6426112
[TBL] [Abstract][Full Text] [Related]
5. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
Ozcan A; Korkmaz A; Oter S; Coskun O
Arch Toxicol; 2005 Aug; 79(8):461-5. PubMed ID: 15800758
[TBL] [Abstract][Full Text] [Related]
6. Cyclophosphamide-induced Down-Regulation of Uroplakin II in the Mouse Urinary Bladder Epithelium is Prevented by S-Allyl Cysteine.
Abdi SA; Najmi AK; Raisuddin S
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):598-603. PubMed ID: 27234646
[TBL] [Abstract][Full Text] [Related]
7. [Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
Schmähl D; Habs M; Tacchi AM
Urologe A; 1984 Sep; 23(5):291-6. PubMed ID: 6438859
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
Andriole GL; Sandlund JT; Miser JS; Arasi V; Linehan M; Magrath IT
J Clin Oncol; 1987 May; 5(5):799-803. PubMed ID: 3106585
[TBL] [Abstract][Full Text] [Related]
9. The prevention of cyclophosphamide-induced bladder swelling in the rat by I.V. administration of sodium-2-mercaptoethane sulfonate.
Kedar A; Simpson CL; Williams P; Moore R; Tritsch G; Murphy GP
Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):339-48. PubMed ID: 6774389
[TBL] [Abstract][Full Text] [Related]
10. [Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
Iwasaku-Fujimoto M; Fujiwara F; Todo S; Morioka Y; Imashuku S
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):403-6. PubMed ID: 2106836
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of 2-mercaptoethanol sodium sulfonate (Mesnum) in the prevention of hemorrhagic cystitis in patients undergoing bone marrow transplantation].
Grañena A; Gardella S; Marín P; Carreras E; Montserrat E; Rozman C
Sangre (Barc); 1986; 31(3):307-10. PubMed ID: 3092373
[No Abstract] [Full Text] [Related]
12. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.
Luce JK; Simons JA
Med Pediatr Oncol; 1988; 16(6):372-4. PubMed ID: 3143903
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow transplantation for Wiskott-Aldrich syndrome: report of 2 cases with use of 2-mercaptoethane sulfonate.
Goldsobel AB; Ehrlich RM; Mendoza GR; Stiehm ER
Transplantation; 1985 May; 39(5):568-70. PubMed ID: 3922097
[No Abstract] [Full Text] [Related]
14. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study.
Hows JM; Mehta A; Ward L; Woods K; Perez R; Gordon MY; Gordon-Smith EC
Br J Cancer; 1984 Dec; 50(6):753-6. PubMed ID: 6437430
[TBL] [Abstract][Full Text] [Related]
15. Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicity.
Cavalletti E; Tofanetti O; Zunino F
Cancer Lett; 1986 Jul; 32(1):1-6. PubMed ID: 3091245
[TBL] [Abstract][Full Text] [Related]
16. Electron microscopic investigations of the cyclophosphamide-induced lesions of the urinary bladder of the rat and their prevention by mesna.
Themann H; Oberdorf E; Brock N; Pohl J
Urol Int; 1987; 42(1):37-43. PubMed ID: 3109094
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of urotoxic complications during therapy with cytostatics. The problem of the interaction between sodium-II-mercaptoethanesulfonate and cyclophosphamide].
Possinger K; Ehrhart H; Misera C; Hartenstein R
Fortschr Med; 1981 Oct; 99(40):1650-2. PubMed ID: 6795099
[No Abstract] [Full Text] [Related]
18. Protective Effects of Caffeic Acid Phenethyl Ester on Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats.
Uysal E; Yılmaz HR; Ugan Y; Altuntas A; Dogru A; Kutlucan A; Tunc SE
J Biochem Mol Toxicol; 2015 Dec; 29(12):559-63. PubMed ID: 26207616
[TBL] [Abstract][Full Text] [Related]
19. Mesna versus forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplant patients (preliminary data).
Hows J; Mehta A; Gordon-Smith EC
Cancer Treat Rev; 1983 Sep; 10 Suppl A():53-6. PubMed ID: 6414696
[No Abstract] [Full Text] [Related]
20. [Evaluation of the benefits of sodium 2-mercaptoethane sulfonate (MESNA) therapy for children undergoing high-dose chemotherapy].
Sato J; Takaue Y; Saito S; Okamoto Y; Hirao A; Shimizu T; Abe T; Watanabe T; Kawano Y; Ninomiya T
Rinsho Ketsueki; 1993 Jan; 34(1):7-12. PubMed ID: 8450612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
